首页> 外文期刊>BioMed research international >Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy
【24h】

Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy

机译:Nomogram预测在中国人群上尿道上皮癌行肾切除术后的肾功能不全:排除辅助化疗的不合格候选人

获取原文
获取外文期刊封面目录资料

摘要

Objectives.To report the decline of renal function after radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC) patients and to develop a nomogram to predict ineligibility for cisplatin-based adjuvant chemotherapy (AC).Methods.We retrospectively analyzed 606 consecutive Chinese UTUC patients treated by RNU from 2000 to 2010. We chose an eGFR of 60 and 45 ml/min/1.73 m2as cut-offs for full-dose and reduced-dose AC eligibility.Results.Median eGFR for all patients before and after surgery was 64 and 49 ml/min/1.73 m2(P<0.001). The proportion of patients ineligible to receive full-dose and reduced-dose AC changed from 42% to 74% and from 20% to 38.1%. Older age (OR = 1.007), preoperative eGFR (OR = 0.993), absence of hydronephrosis (OR = 0.801), smaller tumor size (OR = 0.962), and tumor without multifocality (OR = 0.876) were predictive for ineligibility for full-dose AC. Preoperative eGFR (OR = 0.991), absence of hydronephrosis (OR = 0.881), tumor located in renal pelvis (OR = 1.164), and smaller tumor size (OR = 0.969) could predict ineligibility for reduced-dose AC. The c-index of the two models was 0.757 and 0.836. Postoperative renal function was not associated with worse survival.Conclusions.Older age, lower preoperative eGFR, smaller tumor size, tumor located in renal pelvis, and absence of hydronephrosis or multifocality were predictors of postoperative renal insufficiency.
机译:目的:报告上尿路尿路上皮癌(UTUC)患者行根治性肾切除术(RNU)后肾功能下降的情况,并制作诺模图以预测是否适合进行基于顺铂的辅助化疗(AC)。从2000年至2010年接受RNU治疗的UTUC患者。我们选择eGFR分别为60和45μml/ min /1.73μm2作为完全剂量和减少剂量AC资格的临界值。结果。术前和术后所有患者的eGFR中位数为64和49μml/ min /1.73μm2(P <0.001)。不适合接受全剂量和减量AC的患者比例从42%变为74%,从20%变为38.1%。年龄较大(OR = 1.007),术前eGFR(OR = 0.993),无肾积水(OR = 0.801),较小的肿瘤大小(OR = 0.962)和无多灶性肿瘤(OR = 0.876)可以预测是否符合剂量AC。术前eGFR(OR = 0.991),无肾积水(OR = 0.881),位于肾盂的肿瘤(OR = 1.164)和较小的肿瘤大小(OR = 0.969)可以预示不宜使用减量AC。两种模型的c指数分别为0.757和0.836。结论年龄较大,术前eGFR较低,肿瘤大小较小,肿瘤位于肾盂,无肾积水或多灶性是术后肾功能不全的预示因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号